Story excerpt provided by Cincinnati Business Courier.
Written by Barrett J. Brunsman.
Myriad Genetics, the Utah firm that agreed to buy Mason-based Assurex Health in a deal that could be worth up to $410 million, has a Cincinnati connection.
Dr. Rick Wenstrup, chief medical officer of Myriad (NASDAQ: MYGN), helped invent the technology that Assurex Health’s genetic tests are based on when he was a professor at Cincinnati Children’s Hospital Medical Center.
Click here to read the complete article.
Originally published August 16, 2016.